Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 6/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | SELP | P16109 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL6509718 | 0.91 | PYGB (0.36) | PYGBHDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL6886071 | 0.79 | PYGB (0.41) | PYGBSELPGAA | |
| SCHEMBL6515149 | 0.75 | DNM1 (0.35) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL6515145 | 0.75 | DNM1 (0.35) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| Hydrogen Sulfide SCHEMBL4468953 | 0.73 | PYGB (0.40) | PYGBSELPGAA | |
| Hydrochloric Acid SCHEMBL2536717 | 0.72 | DNM1 (0.49) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL4461207 | 0.68 | PYGB (0.32) | PYGBSELPGAASLC5A1 | |
| Hydrogen Sulfide SCHEMBL6886073 | 0.66 | PYGB (0.47) | PYGBSELPGAA | |
| SCHEMBL17962617 | 0.65 | EPHX2 (0.40) | PYGBEPHX2SELPGAA | |
| SCHEMBL20161703 | 0.65 | PYGB (0.51) | PYGBSELPGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050272670-A1 | Synthesis and use of glycodendrimer reagents | DAVIS BENJAMIN G | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272670-A1 | Synthesis and use of glycodendrimer reagents | STT3A, PTMS, STT3B | PYGB 1271/4885HDAC3 4303/4885HDAC1 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.